Skin Cancer

Sherrif F. Ibrahim, MD, PhD, presents the case of a 49-year-old White woman with neglected large basal cell carcinoma.

Expert dermatologists discuss future directions for the management of basal cell carcinoma.

Sherrif F. Ibrahim, MD, PhD, and Vishal Patel, MD, FAAD, FACMS, discuss the impact of immune checkpoint inhibitors used in BCC.

Experts in dermatology discuss the treatment landscape for BCC.

Precision medicine may help improve the diagnosis and management of melanoma.

Bristol Myers Squibb’s nivolumab shows potential for treatment in earlier stages of melanoma.

Drs Sherrif F. Ibrahim and Vishal Patel discuss the importance of a multidisciplinary team in the treatment of BCC as well as best practices for preventing advanced BCC.

Sherrif F. Ibrahim, MD, PhD, and Vishal Patel, MD, FAAD, FACMS, provide an overview of BCC and discuss disease burden.

At a poster session at the Skin of Color Update meeting in New York City, investigators looked at skin cancer education and prevention among patients with skin of color.

Susan Taylor, MD, FAAD, discusses how an individual can select a sunscreen as well as barriers to using them.

Dr Susan Taylor, an expert dermatologist, discusses how to increase awareness and avoid misconceptions for individuals using sunscreens.

Susan Taylor, MD, FAAD, discusses how to select a sunscreen based on different patient characteristics.

Expert dermatologist, Susan Taylor, MD, FAAD, discusses available sunscreen options to patients.

Susan Taylor, MD, FAAD, discusses FDA regulations for sunscreens.

Susan Taylor, MD, FAAD, addresses gaps in understanding damage to the skin by the general population.

Expert dermatologist Susan Taylor, MD, FAAD, provides education to community dermatologists about the pathophysiology of skin damage

Susan Taylor, MD, FAAD, compares how skin damage can occur in individuals with skin of color compared with individuals with light skin.

Susan Taylor, MD, FAAD, provides an overview of sun-caused skin damage.

Advances in imaging may help gather more datasets on tumor development from a single experiment.

George Martin, MD and Ted Rosen, MD gave a 2-part comprehensive presentation on the changing landscape of cutaneous oncology at Maui Derm NP + PA Summer 2022.

Click here to answer this week's poll.

Software helps expedite access to dermatology appointments.

Study shows nearly 50% reduction in benign lesions excised.

Frozen primary tumor samples will allow researchers to track lesions as they evolve and better understand the characteristics and biomarkers that distinguish aggressive melanomas.

Research does not establish causality, but reveals significant relationships between food choices and melanoma thickness.

In this week’s Pointers with Dr Portela, the 208SkinDoc talks about the end of Melanoma Awareness Month and gives advice on how to prevent skin cancer.

Recent research puts the role of sunscreens in a whole new light. Roger Ceilley MD, FAAD, FACMS outlined need-to-know information on SPF, how to improve adherence and address patient concerns about sunscreen safety and more at the 2022 Fall Clinical Dermatology Conference for PAs & NPs.

Authors suggest not practice changes but more research.

New synthetic small molecule aims to counter drug resistance in BRAF-mutated melanomas.

Will drinking caffeinated coffee reduce skin cancer risk? Is gene expression profiling set to become mainstream testing for melanoma? See what Darrell S. Rigel, MD, MS, FAAD, has to say.